Breaking News

ARTBIO, Nucleus RadioPharma Enter Manufacturing & Supply Pact

Nucleus to manufacture GMP-Grade therapeutic products containing Radioisotope Pb-212 to support clinical trials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ARTBIO, Inc., a clinical-stage radiopharmaceutical company developing a new class of targeted alpha radioligand therapies (ARTs), and Nucleus RadioPharma Inc., an integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, entered a strategic manufacturing and supply agreement to support ARTBIO’s therapeutic product manufacturing.   Under the agreement, Nucleus will manufacture ARTBIO’s 212Pb-radiolabeled therapies for its planned Phase I and II clinical tria...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters